Bone Marrow TransplantationTransplantation, HomologousGraft vs Host DiseaseBone MarrowCytomegalovirus InfectionsLeukemiaBone Marrow CellsWhole-Body IrradiationTissue DonorsCytomegalovirusAnemia, AplasticImmunosuppressive AgentsImmunocompromised HostHematologic NeoplasmsOpportunistic InfectionsCyclosporineMycosesGraft SurvivalTransplantation ConditioningLeukemia, Myeloid, AcuteMucormycosisTransplantation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFatal OutcomeTime FactorsImmunosuppressionAdenovirus Infections, HumanGanciclovirAcute DiseaseTransplantation, AutologousKidney TransplantationAspergillosisHematopoietic Stem Cell TransplantationRetrospective StudiesLymphocyte DepletionGraft RejectionRecurrencePneumonia, ViralPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte TransfusionBone and BonesNuclear FamilyHistocompatibility TestingPolymerase Chain ReactionHematopoietic Stem CellsViremiaAspergillusTreatment OutcomeAntiviral AgentsHistocompatibilityDNA, ViralT-LymphocytesRadiation ChimeraRemission InductionNocardia InfectionsBusulfanAntifungal AgentsSurvival AnalysisCombined Modality TherapyGraft vs Host ReactionAmphotericin BMice, Inbred C57BLLeukocyte TransfusionNeutropeniaGraft vs Tumor EffectProspective StudiesTransplantationTransplantation, IsogeneicBone Marrow PurgingBone Marrow DiseasesHematopoiesisCystitisBK VirusPostoperative ComplicationsBone Marrow ExaminationOrgan TransplantationHeart TransplantationCyclophosphamideLeukemia, MyeloidHLA AntigensBone Marrow NeoplasmsMyelodysplastic SyndromesChimeraLung TransplantationTransplantation ImmunologyHepatic Veno-Occlusive DiseaseTacrolimusGraft vs Leukemia EffectHematologic DiseasesMice, Inbred BALB CLiver TransplantationTransplantsBone RemodelingSpleenFollow-Up StudiesColony-Forming Units AssaySurvival RateAntilymphocyte SerumImmunoglobulins, IntravenousRisk Factors